GlassScriptPhysician profile
Deborah K Chen
NPI 1639675416
$1,395.52
in general payments reported to CMS, 2019-2025
12 companies · $61.69 in 2025
The $61.69 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $74.23 · 2023: $400 · 2024: $860 · 2025: $61.69.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $870 · Travel and Lodging: $353 · Education: $99.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $869.67 |
| Travel and Lodging | $352.62 |
| Education | $99.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coloplast Corp | $650.62 | 2024 | |
| Astellas Pharma US INC | $281.21 | 2023-2024 | Veozah |
| Sumitomo Pharma America, INC. | $126.76 | 2023 | Myfembree |
| Amgen INC. | $104.81 | 2023-2025 | Evenity, Prolia, Prolia |
| Medtronic, INC. | $62.47 | 2022 | |
| Pfizer INC. | $43.58 | 2023-2025 | |
| Dexcom, INC. | $25.37 | 2025 | Dexcom G6 Transmitter |
| Abbvie INC. | $25.16 | 2022-2023 | Orilissa |
| Exact Sciences Corporation | $20.58 | 2023 | Cologuard Collection Kit |
| Biogen, INC. | $19.68 | 2024 | |
| Novo Nordisk INC | $18.01 | 2024 | Wegovy |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $17.27 | 2023 | Xifaxan |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Deborah Chen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.